• Accueil >
  • Publications >
  • Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study

Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study

1 févr. 2020The Breast

DOI : 10.1016/j.breast.2019.10.002

Auteurs

Jean-Philippe Jacquin, Lionel Uwer, Alexia Savignoni, Jean-Marc Ferrero, Alain Lortholary, David Solub, Flore Delaporte, Nassera Chalabi, Sophie Pibre, Yazid Belkacemi